Is Minnesota Approaching Psychedelics Decriminalization? Medical Association Votes Yes
[ad_1] The Minnesota Medical Association (MMA) has recently released a resolution calling for the removal of penalties for possession of small amounts of illicit drugs as well as promoting statewide…
Israeli Psychedelics Biotech Shares Latest Advancements, Moves Forward With Addictions Treatment – Clearmind Medicine (NASDAQ:CMND)
[ad_1] Psychedelics company Clearmind Medicine Inc. CMND aims to bring its proprietary compound, CMND-100, to clinical trials while developing additional proprietary psychedelic compounds for next-generation novel drug candidates, according to…
Psyence, Revive Therapeutics Ink Private Placements: Capital To Support Drug Trials – Psyence Group (OTC:PSYGF), Revive Therapeutics (OTC:RVVTF)
[ad_1] Life sciences biotech Psyence Group Inc. PSYGF has closed the second tranche of its previously announced private placement of up to $2.2 million (CA$3 million). The company issued more…
Awakn Unveils Q3 Results, Touts Revenue Growth, R&D Progress, Commercial Plans – Awakn Life Sciences (OTC:AWKNF)
[ad_1] Psychedelics biotech Awakn Life Sciences Corp. AWKNF shared its financial results and business highlights for a three-month period that ended Oct. 31, 2022. Financials showed: Revenue of $314.827…
FDA Green Lights New Study Testing IV Ketamine Infusion For Depressive Disorder – Ehave (OTC:EHVVF)
[ad_1] After a full review of healthcare provider Ehave Inc.‘s EHVVF IND application, the U.S. Food and Drug Administration (FDA) has authorized the company to proceed with a clinical trial…